Zantac cancer risk by type and safe alternatives - Medical News Today
2022年8月19日 · The drug Zantac can elevate the risk of a person developing cancer. The active ingredient, ranitidine, contains a contaminant called NDMA, which is a probable human carcinogen.
The FDA Announces Two More Antacid Recalls Due to Cancer Risk
2020年1月10日 · Two more companies recalled their ranitidine drugs, generic forms of Zantac, over concerns they may contain a carcinogenic substance.
Zantac Lawsuit: Status, Eligibility, & Settlements - Drugwatch
2024年11月1日 · FDA found Zantac’s active ingredient ranitidine contained N-Nitrosodimethylamine (‘NDMA’) — a probable human carcinogen. One plaintiff, using the initials VB to protect her privacy, told Drugwatch that she filed a Zantac lawsuit after she lost her husband to stomach cancer.
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2
2024年10月9日 · GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on...
What We Know about the Possible Carcinogen Found in Zantac
2019年10月28日 · The popular heartburn drug may produce potentially unsafe levels of NDMA when its active ingredient breaks down. French drugmaker Sanofi recently announced a recall of over-the-counter Zantac,...
What’s the Link Between Zantac and Kidney Cancer? - Healthline
2022年10月25日 · A chemical compound found in Zantac called NDMA is classified as a probable carcinogen. Learn about the potential link between Zantac and kidney cancer.
Popular heartburn drug ranitidine recalled: What you need to …
2019年10月1日 · If you or a family member take ranitidine (Zantac) to relieve heartburn, you may have heard that the FDA has found a probable human carcinogen (a substance that could cause cancer) in it. The story is unfolding quickly and many details remain murky.
Ranitidine Use and Incident Cancer in a Multinational Cohort
This cohort study examines the comparative risk of cancer associated with the use of ranitidine vs other histamine-2 receptor antagonists.
Ranitidine Use and Cancer Risk: Results From UK Biobank
2020年10月22日 · Regular ranitidine use (yes/no) was associated with a non-significant decreased risk of kidney cancer (HR, 0.53; 95% CI, 0.27–1.02); this association strengthened to statistical significance in active comparator analyses (HR, 0.39; 95% CI, 0.19–0.82).
Zantac’s Maker Kept Quiet About Cancer Risks for 40 Years
2023年2月15日 · Zantac’s Maker Kept Quiet About Cancer Risks for 40 Years. Glaxo says the heartburn drug doesn’t cause tumors. But the company was warned by its own scientists and independent researchers ...